Pfizer Inc. and Ranbaxy Laboratories Deal Would Delay Generic Lipitor

NEW YORK (Reuters) - Pfizer Inc. said on Wednesday that Ranbaxy Laboratories Ltd can begin selling a U.S. generic form of its Lipitor cholesterol fighter by late 2011 under a settlement deal, some five months later than Wall Street expectations.